Advances of Genomic Medicine in Psoriatic Arthritis
- PMID: 35055350
- PMCID: PMC8780979
- DOI: 10.3390/jpm12010035
Advances of Genomic Medicine in Psoriatic Arthritis
Abstract
Psoriatic arthritis (PsA) is a common type of inflammatory arthritis found in up to 40% of patients with psoriasis. Although early diagnosis is important for reducing the risk of irreversible structural damage, there are no adequate screening tools for this purpose, and there are no clear markers of predisposition to the disease. Much evidence indicates that PsA disorder is complex and heterogeneous, where genetic and environmental factors converge to trigger inflammatory events and the development of the disease. Nevertheless, the etiologic events that underlie PsA are complex and not completely understood. In this review, we describe the existing data in PsA in order to highlight the need for further research in this disease to progress in the knowledge of its pathobiology and to obtain early diagnosis tools for these patients.
Keywords: epigenomics; genome-wide association studies; genomics; personalized medicine; psoriatic arthritis; spondyloarthropathies; transcriptomics.
Conflict of interest statement
Carlos M. Laborde and Leyre Larzabal are currently employees of Dreamgenics, Inc. The authors declare no conflict of interest.
Figures
References
-
- Alinaghi F., Calov M., Kristensen L.E., Gladman D.D., Coates L.C., Jullien D., Gottlieb A.B., Gisondi P., Wu J.J., Thyssen J.P., et al. Prevalence of Psoriatic Arthritis in Patients with Psoriasis: A Systematic Review and Meta-Analysis of Observational and Clinical Studies. J. Am. Acad. Derm. 2019;80:251.e19–265.e19. doi: 10.1016/j.jaad.2018.06.027. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous